# Ecuador Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Ecuador HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Ecuador (ECU)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $3.3M
- Products: 23
- Buyer markets: 25
- Average CAGR: +2.1%
- Global sector size: $521.5B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $270.4B | $2.2M | $97.0B | -2.7% | 18 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $86.4B | $19.6K | $35.5B | +37.9% | 3 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $27.5B | $131.4K | $18.9B | -4.6% | 11 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $28.6B | $155.4K | $15.6B | +25.2% | 6 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $223.8K | $10.7B | +4.3% | 3 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $9.8B | $324.9 | $10.1B | -9.6% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $116.0K | $8.8B | +2.3% | 5 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $16.1B | $228.2 | $7.9B | -22.8% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $15.0B | $16.5K | $6.2B | -2.8% | 5 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.2B | $198.5 | $5.7B | -13.7% | 2 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $10.0B | $93.9K | $5.7B | -2.2% | 4 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $6.8K | $2.2B | -0.8% | 2 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $30.1K | $2.0B | +5.3% | 1 | +0.0% |
| HS 284590 - Isotopes (excluding those of heading no. 2844): compounds, inorganic or organic, of such isotopes, whether or not chemically defined | $1.1B | $4.6 | $1.9B | +0.0% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $209.9K | $1.9B | +21.2% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $3.6B | $1.8K | $1.8B | +3.2% | 2 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $147.4 | $1.4B | -18.9% | 1 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $18.0 | $1.3B | -17.1% | 1 | +0.0% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $481.1 | $841.5M | -11.3% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $1.5K | $803.3M | -0.6% | 1 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $861.3M | $286.4 | $801.0M | +132.8% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $734.9M | $11.6K | $798.7M | +1.6% | 1 | +0.0% |
| HS 300432 - Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | $1.9B | $105.5K | $746.2M | +23.6% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $76.7B calculated opportunity across 15 products.
- Switzerland, Liechtenstein (CHE): $31.0B calculated opportunity across 2 products.
- Belgium (BEL): $21.4B calculated opportunity across 5 products.
- Germany (DEU): $19.5B calculated opportunity across 8 products.
- Netherlands (NLD): $11.5B calculated opportunity across 3 products.
- Canada (CAN): $10.2B calculated opportunity across 6 products.
- Spain (ESP): $9.8B calculated opportunity across 5 products.
- China (CHN): $9.0B calculated opportunity across 3 products.
- France (FRA): $8.6B calculated opportunity across 6 products.
- United Kingdom (GBR): $7.5B calculated opportunity across 5 products.
- Mexico (MEX): $6.9B calculated opportunity across 3 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.

## Growth stars

- HS 381512: +132.8% average CAGR, $801.0M calculated opportunity.
- HS 300215: +37.9% average CAGR, $35.5B calculated opportunity.
- HS 300212: +25.2% average CAGR, $15.6B calculated opportunity.
- HS 300432: +23.6% average CAGR, $746.2M calculated opportunity.
- HS 382319: +21.2% average CAGR, $1.9B calculated opportunity.
- HS 300420: +5.3% average CAGR, $2.0B calculated opportunity.
- HS 330210: +4.3% average CAGR, $10.7B calculated opportunity.
- HS 300290: +3.2% average CAGR, $1.8B calculated opportunity.
- HS 330499: +2.3% average CAGR, $8.8B calculated opportunity.
- HS 293399: +1.6% average CAGR, $798.7M calculated opportunity.

## Diversification opportunities

- HS 300490: 18 buyer markets, $97.0B calculated opportunity.
- HS 382499: 11 buyer markets, $18.9B calculated opportunity.
- HS 300212: 6 buyer markets, $15.6B calculated opportunity.
- HS 330499: 5 buyer markets, $8.8B calculated opportunity.
- HS 382200: 5 buyer markets, $6.2B calculated opportunity.
- HS 300439: 4 buyer markets, $7.9B calculated opportunity.
- HS 330300: 4 buyer markets, $5.7B calculated opportunity.
- HS 300215: 3 buyer markets, $35.5B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 300220: 3 buyer markets, $10.1B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.